Clinical use of growth factors in chronic renal failure

Anitha Vijayan, Terry Behrend, Steven B. Miller

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Erythropoietin has been demonstrated to improve the quality of life in patients with chronic renal failure, and growth hormone has been approved for use in children with chronic renal failure and short stature as a growth promoting agent. Growth factors also have great therapeutic potential to improve glomerular function in the setting of chronic renal failure. Further studies are required to delineate the role of insulin-like growth factor I in the setting of end-stage chronic renal failure.

Original languageEnglish
Pages (from-to)5-10
Number of pages6
JournalCurrent Opinion in Nephrology and Hypertension
Issue number1
StatePublished - Jan 21 2000


Dive into the research topics of 'Clinical use of growth factors in chronic renal failure'. Together they form a unique fingerprint.

Cite this